drugset / Trial / NCT07535606
A Study to Evaluate ALN-4915 in Adult Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of ALN-4915.
Timeline
- Start
- 2026-03-02
- Primary completion
- 2027-07-31
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALN-4915 | Unknown | — | Subcutaneous |
Indications
No indication recorded.